|
|
Zooming In on the Education and Empowerment of Patients in AMD Care
FDA-approved agents that target vascular endothelial growth factor (VEGF) constitute important elements of optimal management of AMD. Prior authorization (PA) requirements limit patient access to these therapies. Navigating the PA process can be frustrating for patients, and may result in treatment abandonment leading to suboptimal outcomes. Hence, there is a need for patients to become advocates of their treatment choice.
The final module of this CME Outfitters Snack series describes step ... |
|
|
Minimizing the Burden of Prior Authorization in AMD Through Actionable Strategies and Improved Communication
The development of anti–vascular endothelial growth factor (VEGF) agents has revolutionized the treatment of age-related macular degeneration (AMD). Nevertheless, optimal management of AMD is impeded by challenges in access to FDA-approved therapies. Step therapy, a type of prior authorization (PA) instituted by the payer, mandates that more cost-effective therapies be used before more expensive alternatives, in a stepwise approach. However, applying this strategy to vision-threatening disea... |
|
|
Keeping the Patient in the Center in AMD Care
Age-related macular degeneration (AMD) is the leading cause of legal blindness in adults over age 50, but the development of agents that target vascular endothelial growth factor (VEGF) has revolutionized its treatment. There are currently two FDA-approved agents (ranibizumab and aflibercept) and one off-label anti-VEGF agent (bevacizumab) being used to treat patients with AMD, and data from emerging anti-VEGF agents have also demonstrated efficacy in improving visual acuity. However, step the... |
|
|
5-Night Banff CME AWAY® Resort
Moose Hotel & Suites
The design of The Moose is “mountain elegance”, with warm, rich, natural materials. Located a 1 minute walk from the heart of downtown Banff, the Moose Hotel & Suites features 174 air conditioned guests rooms, with a combination of One and Two Bedroom Suites and hotel rooms. Amenities include the Meadow Spa & Pools with 10 treatment rooms and private outdoor hot pool, a bright indoor swimming pool and exercise room on the 3rd floor, and 2 spectacular rooftop hot pools... |
|
|
14-Night South Africa CME AWAY® Cruise - Medical Emergencies, Dental Disease & Its Relationship To Systemic Medical Conditions
Cape Town, South Africa | Walvis Bay, Namibia | Port Elizabeth, South Africa | Durban, South Africa | Maputo, Mozambique |Richards Bay, South Africa | Mossel Bay, South Africa
|
|
|
7-Night Whistler CME AWAY Resort - From A to V in Primary Care & Lots in Between: Afib, Diabetes, Infectious Disease, Menopause, Obesity, Pain and Vaccines
Whistler Ski Resort |
|
|
11-Night Portugal, Spain & France CME AWAY® Cruise
Lisbon, Portugal ● Porto (Leixoes), Portugal ● Bilbao, Spain ● Bordeaux, France ● Nantes, Loire Valley, France ● St. Peter Port, Channel Islands ● Southampton, England |
|
|
8-Night Rome & Amalfi Coast CME AWAY® Land Tour
Rome, Italy ● Montecassino, Italy ● Amalfi Coast, Italy ● Minori, Italy ● Sorrento, Italy ● Pompeii, Italy |
|
|
7-Night Costa Mujeres CME AWAY® Resort - Addiction and Family Medicine
Grand Palladium Costa Mujeres & TRS Coral, Costa Mujeres, Mexico |
|
|
Danube River Cruise on Crystal: Exploring Medicine, Dentistry & the European Healthcare Model
Danube River Cruise on Crystal
Exploring Medicine, Dentistry &
the European Healthcare Model
Budapest to Vilshofen on Crystal Ravel
September 19 – 26, 2021
Join PES for 7 nights & discover the heart of Old-World Europe, exploring timeless imperial cities and the plentiful UNESCO World Heritage Sites along the regal & romantic Danube River aboard the luxurious, 106-guest all-inclusive, all-suite, butler-serviced Crystal Ravel.
River Cruise Itinerary Highlights:
Overnight in Budapes... |
|
|
10-Night Canadian Maritimes Coastal Wonders CME AWAY® Land Tour
Halifax, Nova Scotia | Peggy’s Cove | Mahone Bay | Lunenburg | Cape Breton Island | Baddeck | Cabot Trail | Prince Edward Island | Saint John, New Brunswick |
|
|
6-Night Canadian Rockies & Glacier National Park CME AWAY® Land Tour
Calgary, Alberta | Waterton Lakes National Park, Alberta | Glacier National Park, Montana | Banff, Alberta | Icefields Parkway, Alberta | Lake Louise, Alberta |
|
|
14-Night Black Sea CME AWAY® Cruise - Palliative Care for the Generalist & Updates on Surgery for the Family Physician
Piraeus (Athens), Greece ● Mykonos, Greece ● Kusadasi (Ephesus), Turkey ● Bosporus Strait (Cruising) ● Burgas, Bulgaria ● Varna, Bulgaria ● Constanta (Bucharest), Romania ● Odessa, Ukraine ● Istanbul, Turkey ● Canakkale (Kepez), Turkey |
|
|
West Coast Culinary Themed Cruise: Medical/Dental Health and Well–Being Updates
West Coast Culinary Themed Cruise
Medical/Dental Health and Well–Being Updates
Vancouver to San Diego on Windstar Star Breeze
September 23 - October 3, 2021
Join PES for a 10-night Western United States culinary themed cruise, to explore bountiful farmer’s markets, famed culinary cities, scenic vineyards, and rugged coastlines—while sailing aboard the newly renovated, 312-guest all-suite yacht Windstar Star Breeze!
Medical/Dental Health and Well–Being Updates
CME/CE Lecture... |
|
|
5-Night Mont Tremblant CME AWAY Resort
Mont-Tremblant Ski Resort, Quebec, Canada - March Break! |
|
|
7-Night Jamaica CME AWAY Resort - Pearls for Managing COPD, Asthma, Different Kinds of Arthritis, Sleep Disorders & Communicating with our Patients
Sandals South Coast, Jamaica |
|
|
7-Night St. Lucia CME AWAY Resort - Updates in Psychiatry & Dermatology
Sandals Grande St. Lucian, Pigeon Island Gros Islet, St. Lucia |
|
|
Diabetic Eye Disease: Expert Discussions on How and When to Treat
Retinal disorders, including age-related macular degeneration, diabetic eye disease, and retinal vein occlusion can result in vision loss if not treated early and continuously. Prevent Blindness America has found the total health care costs of vision problems in the United States in people older than 40 years to reach almost $139 billion annually. Retina specialists must be continuously educated on the latest advances relating to the management of these diseases to allow for the best possible ... |
|
|
11-Night Cook Islands & Society Islands CME AWAY Cruise - Family Medicine & Dermatology
Papeete, Tahiti, Society Islands ● Huahine, Society Islands ● Aitutaki, Cook Islands ● Rarotonga, Cook Islands ● Bora Bora, Society Islands ● Taha'a, Society Islands ● Moorea, Society Islands |
|
|
10-Night Galapagos Islands CME AWAY™ Cruise - Family Medicine, Breast Cancer & Orthopedic Surgery
Quito, Ecuador ● Baltra ● Isla Daphne Grande ● Bahia Darwin ● El Barranco ● Seymour Norte ● Santiago Rabida ● Santa Cruz ● San Cristobal ● Punta Pitt ● Gardner Bay ● Punta Suarez ● Estacion Darwin ● Puerto Ayora ● Plazas Sur |
|
|
7-Night Alaska Dawes Glacier CME AWAY™ Cruise - From COPD to Migraines to Arthritis and More! An Interactive CME Program North of 60
Seattle, Washington ● Ketchikan, Alaska ● Endicott Arm ● Juneau, Alaska ● Skagway, Alaska ● Victoria, British Columbia |
|
|
11-Night Spain, Portugal & Canary Islands CME AWAY™ Cruise
Southampton, England • Porto (Leixoes), Portugal • Lanzarote, Canary Islands • Tenerife, Canary Islands • Gran Canaria, Canary Islands • Lisbon, Portugal • Vigo, Spain |
|
|
10-Night Venice, Turkey & Greek Islands CME AWAY™ Cruise
Venice, Italy ● Katakolon, Greece ● Santorini, Greece ● Ephesus (Kusadasi), Turkey ● Mykonos, Greece ● Athens (Piraeus), Greece ● Chania (Souda), Crete, Greece ● Zakynthos, Greece |
|
|
nAMD and Imaging Modalities
This certified CME activity is designed for retina specialists and eye care professionals involved in the medical management of patients with retina disorders.
|
|
|
The Basics of Pigment Epithelial Detachment and the Latest in nAMD Therapies
This certified CME activity is designed for retina specialists and eye care professionals involved in the medical management of patients with retina disorders. |
|
|
The Basics of nAMD Treatment
This certified CME activity is designed for retina specialists and eye care professionals involved in the medical management of patients with retina disorders. |
|
|
Comanaging Premium IOL Patients: Presbyopia Correction
This expert discussion will review how to improve patient outcomes by managing presbyopia-correcting intraocular lenses (IOLs) in today’s optometric practice. This 1-hour program will review how to match patients with the appropriate IOL and optimize their outcomes. Program content will include evidence-based didactic presentations, interactive discussions, and relevant case presentation discussions. |
|
|
Neurotrophic Keratitis: New Approaches to Manage Disease and Improve Patient Satisfaction
CONTENT SOURCE
This continuing medical education (CME)/continuing education (CE) activity captures content from two webcasts.
ACTIVITY DESCRIPTION
Neurotrophic keratitis is a degenerative corneal disease characterized by decreased or absent corneal sensation, which can lead to epithelial breakdown, impairment of healing, and ultimately to the development of corneal ulceration, melting and perforation. Treating neurotrophic keratitis should be prompt and based on the stage and severity of ... |
|
|
Disease Prevalence and Advanced Imaging Modalities
This webcast featuring a dialogue and case studies with a retinal specialist and an optometrist and will review disease prevalence advanced diagnostic imaging pivotal treatment trials and challenging case studies.
Target Audience
This certified COPE activity is designed for optometrists involved in the management of patients with diabetes |
|
|
Diabetic Macular Edema Management
Diabetes is the leading cause of new cases of blindness among adults age 18 to 64 years, according to the Centers for Disease Control and Prevention’s 2020 National Diabetes Statistics Report. This activity reviews the management of patients with diabetic macular edema, with a focus on 1- and 2-year results of the Protocol T clinical trial. |
|
|
New Options in Glaucoma Pharmacology: Targeting the TM
New options have become available in recent years for the medical management of glaucoma. Drs. Khouri and Sawhney discuss the importance of individualized care for patients, with an emphasis on lowering IOP through enhancing trabecular meshwork outflow using novel therapies rather than surgical options as first-line treatment.
TARGET AUDIENCE
This certified CME/CE activity is designed for specialists and other allied eye care practitioners involved in the management of glaucoma and associa... |
|
|
Coordinated Care and the Complex Diabetic Retinopathy Patient
This webcast will feature content designed for the comanagement of patients with advanced diabetic retinopathy. Topics of discussion include stages of retinal disease optimal time for referral telemedicine and the importance of maintaining communication in addition to challenging case studies.
Target Audience
This certified COPE activity is designed for optometrists involved in the management of patients with diabetes. |
|
|
Corneal Disorders: Keratoconus and Corneal Collagen Crosslinking
This discussion will provide optometrists with a comprehensive 30-minute education program on how to improve patient outcomes by diagnosing and managing corneal disorders in today’s optometric practice. The course will focus on patient identification and the latest research results related to comanaging patients with keratoconus, including corneal crosslinking. Program content will include a set of evidence-based didactic presentations, interactive panel discussions, and relevant case pres... |
|
|
Corneal Disorders: Genetic Testing and Neurotrophic Keratitis
This expert discussion will provide optometrists with a comprehensive 15-minute education program on how to improve patient outcomes by diagnosing and managing corneal disorders in today’s optometric practice. The course will focus on patient identification and the latest research results related to comanaging patients with neurotrophic keratitis, including genetic testing. Program content will include a set of evidence-based didactic presentations, interactive panel discussions, and relev... |
|
|
Tackling Ocular Surface Disease: Treating Ocular Surface Diseases
This expert discussion will provide optometrists with a comprehensive 30-minute education program on how to improve patient outcomes by managing ocular surface disease (OSD) in today’s optometric practice. The course will review how to improve OSD treatment decisions. Program content will include a set of evidence-based didactic presentations, interactive discussions, and relevant case presentation discussions. |
|
|
Tackling Ocular Surface Disease: Diagnosing Dry Eye and MGD
This expert discussion will provide optometrists with a comprehensive 30-minute education program on how to improve patient outcomes by managing ocular surface disease (OSD) in today’s optometric practice. The course will demonstrate the impact of the ocular surface on visual quality and review how to improve OSD diagnostic decisions. Program content will include a set of evidence-based didactic presentations, interactive discussions, and relevant case presentation discussions. |
|
|
Comanaging Premium IOL Patients: Astigmatism Correction
This expert panel will review how to improve patient outcomes by managing presbyopia-correcting intraocular lenses (IOLs) in today’s optometric practice. This 1-hour program will review how to match patients with the appropriate IOL and optimize their outcomes. Program content will include evidence-based didactic presentations, interactive panel discussions, and relevant case presentation discussions. |
|
|
The Relationship Between Fluid and BCVA
This activity will review the latest data on how intraretinal fluid and subretinal fluid in the retinal pigment epithelium affects visual acuity in patients with neovascular macular degeneration.
PRIMARY AUDIENCE:
Retina specialists involved in the treatment and management of patients with retina disorders.
|
|
|
AMD Essentials and an RVO Review
This activity focuses primarily on studies that highlight all of the anti-VEGF dosing paradigms investigated in large, randomized clinical trials for the treatment of neovascular age-related macular degeneration plus two case presentations. A brief review of study results for retinal vein occlusion is also included.
PRIMARY AUDIENCE:
Retina specialists involved in the treatment and management of patients with retina disorders.
|
|
|
Gene Therapy: An Emerging Frontier in the Treatment of Neovascular Diseases
CONTENT SOURCE
This continuing medical education (CME) activity captures content from a roundtable discussion.
ACTIVITY DESCRIPTION
There is potential for gene therapy to effectively treat neovascular diseases and eliminate the significant treatment burden. This roundtable discussion includes a review of the latest data, potential utility, and remaining questions surrounding this novel approach for management of neovascular age-related macular degeneration (nAMD).
|
|
|
Ushering in a New Treatment Paradigm for Glaucoma: Updates on Novel Therapeutics and Disease-Modifying Treatments
CONTENT SOURCE
This continuing medical education (CME)/continuing education (CE) activity captures content from a live event.
ACTIVITY DESCRIPTION
Medical/topical therapy is the first-line choice for most physicians treating patients with primary open-angle glaucoma (POAG), yet some patients will have visual field loss despite adequate IOP control. This supplement focuses on the investigative agents that will help deliver treatment in a more consistent and patient-friendly manner. |
|
|
MGD Consensus Panel: Taking Aim at Meibomian Gland Dysfunction
CONTENT SOURCE
This continuing education activity captures content from a roundtable discussion.
ACTIVITY DESCRIPTION:
The following activity focuses on the rising awareness of meibomian gland dysfunction (MGD) and its impact on ocular surface disease.
TARGET AUDIENCE:
This educational activity is intended for optometrists. |
|
|
2nd Annual International OSD Review
A discussion of the progress of the DEWS II TFOS report particularly with a view on what has changed in practice and what more can be derived from the report. |
|
|
Neurotrophic Keratitis: Differential Diagnosis, Treatment Options, and Case Discussions
This CME webinar will highlight the various ways in which neurotrophic keratitis can present and will also include practical information on current and investigative treatment options. The program hosts will discuss challenging cases. |
|
|
A Look at the Glaucoma Armamentarium
This webinar presents the following learning objectives:
Identify the mechanisms of action as well as the efficacy and safety profiles of novel trabecular outflow medications.
Demonstrate proficiency in selecting appropriate therapies to achieve individualized patient-specific treatment goals.
Advocate for patients who would benefit from new drugs before they are incorporated into payors’ formularies. |
|
|
Tailoring Therapy to the Neovascular AMD Patient: Implementing Novel Treatment Strategies to Improve Outcomes
By 2040, an estimated 228 million people worldwide will be diagnosed with age-related macular degeneration (AMD). Treatment with anti-VEGF intravitreal injections has been shown to improve vision by 6 to 10 letters from baseline, but real-world results differ from clinical trial results. Therefore, it is clear that retina specialists need to be fully educated on the various treatment options to deliver the best patient care. |
|
|
New Pharmacotherapeutics for the Treatment of Glaucoma: Targeting the Trabecular Meshwork
CONTENT SOURCE
This continuing medical education (CME)/continuing education (CE) activity captures content from a roundtable discussion.
ACTIVITY DESCRIPTION
The development and commercialization of two new topical glaucoma drugs has renewed interest in medical therapy. In late 2017, after a 2-decade gap in glaucoma pharmacology innovation, two drugs in novel classes were approved for IOP reduction in eyes with ocular hypertension or open-angle glaucoma. These drugs lower IOP through uniq... |
|
|
Excisional Goniotomy for the Cataract Surgeon
This webinar will provide valuable information on how to incorporate certain microinvasive glaucoma surgery (MIGS) procedures into a cataract/refractive practice. |
|
|
Diagnosing, Treating, and Managing Scleritis in 2020
This work is based on a virtual roundtable discussion hosted by Evolve Medical Education LLC.
Although uncommon, scleritis is a dangerous immune-mediated disease that can potentially threaten the structural integrity of the eye and may be indicative of potentially life-threatening systemic vasculitis. Data on the genetic factors of scleritis is lacking, but it is thought that genes affecting systemic autoimmune diseases impact scleritis as well. Differentiating between episcleritis and scl... |
|
|
Navigating the World of Retina: Updates for the Newer Retina Specialist
Retinal disorders, including age-related macular degeneration (AMD) and diabetic macular edema (DME), can result in vision loss if not treated early and—in most cases—continuously. The need for newer retina specialists to be fully educated on the various treatment options remains crucial to delivering the best patient care. In addition, retina specialists new to practice must also navigate the business aspects of their clinics.
TARGET AUDIENCE
This certified CME activity is designed fo... |
|